Iradimed (IRMD) Set to Announce Earnings on Thursday

Iradimed (NASDAQ:IRMD) is set to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of $0.31 per share for the quarter. Iradimed has set its FY 2024 guidance at 1.520-1.620 EPS and its Q1 2024 guidance at 0.330-0.350 EPS.Parties interested in registering for the company’s conference call can do so using this link.

Iradimed (NASDAQ:IRMD) last issued its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.36 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.01). The business had revenue of $17.45 million for the quarter. Iradimed had a return on equity of 24.62% and a net margin of 26.22%. On average, analysts expect Iradimed to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Iradimed Stock Performance

IRMD traded up $0.11 on Tuesday, reaching $41.01. The company had a trading volume of 10,124 shares, compared to its average volume of 50,966. Iradimed has a 52-week low of $36.12 and a 52-week high of $51.04. The company has a market cap of $519.19 million, a price-to-earnings ratio of 30.07 and a beta of 0.82. The business has a 50 day simple moving average of $42.65 and a 200 day simple moving average of $43.09.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on IRMD shares. Singular Research reiterated a “buy” rating on shares of Iradimed in a research report on Monday, April 1st. Roth Mkm reaffirmed a “buy” rating and issued a $65.00 target price on shares of Iradimed in a research note on Monday, April 22nd. Finally, Roth Capital reissued a “buy” rating on shares of Iradimed in a research note on Monday, April 22nd.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.